Fresenius Kabi Company Description
Fresenius Kabi isn't one to stray from the sight of blood; to the contrary, the company's life depends on it. A subsidiary of Fresenius SE -- to which it contributes more than 15% of its annual sales -- the unit is a leading provider of a variety of transfusion products and devices. Fresenius Kabi's Voluven product is the top-selling artificial colloid -- a blood volume substitute used after trauma -- outside North America. Other infusion products include products for fluid and blood replacement, generic anesthetics and other IV-administered drugs, and medical devices such as insulin delivery pumps. Fresenius Kabi also produces clinical nutrition products for patients who are unable to digest normal food.
View the Comprehensive Company Description for Fresenius Kabi
The Company Description provides a historical perspective of Fresenius Kabi's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Fresenius Kabi's evolution in the marketplace.
